Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2019-01-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
第二届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board (监事会) of the company 西藏易明西雅医药科技股份有限公司. It details the convening of the second Supervisory Board's fourth meeting, the attendance, the agenda item about changing some fundraising investment projects, and the voting results. There is no financial data, no detailed report, no audit information, no earnings data, and no mention of an annual or interim report. The document is a formal announcement of a board/committee meeting resolution, which fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2019-01-22 Chinese
关于变更部分募集资金投资项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the change in the use of part of its previously raised funds (募集资金). It details the original fundraising, the projects funded, the proposed changes to the investment projects, reasons for the change, and the approval process including board and independent director opinions. It also states that the proposal will be submitted to the shareholders' meeting for approval. The document is not a full financial report, audit report, or earnings release, but rather a formal announcement about changes in capital use and investment projects. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is sufficient and contains substantive information about the capital use change, not just a brief notice or a report publication announcement.
2019-01-22 Chinese
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (830 characters) regarding the partial release of pledged shares by a controlling shareholder. It details the number of shares pledged and released, dates, and percentages of ownership. There is no financial data, no mention of financial results, no management discussion, no audit information, or any other report content. It is a regulatory announcement about share pledge status, which fits best under a regulatory filing category. It is not a report itself but an announcement of a corporate event related to share pledging. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-01-22 Chinese
独立董事关于第二届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding matters discussed at the company's second board of directors' fourth meeting. It references regulatory guidelines related to independent directors and board meetings, and discusses approval of changes to investment projects funded by raised capital. The document is a formal opinion letter from independent directors, not a full financial report, earnings release, or regulatory filing. It is related to board/management information as it concerns board meeting matters and independent director opinions. The document length is short and it is not an announcement of a report publication. Therefore, it fits best under Board/Management Information (MANG).
2019-01-22 Chinese
第二届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the second board meeting of the company, including approval of changes to fundraising investment projects and the proposal to convene an extraordinary general meeting. It details the meeting attendance, voting results, and references to related disclosures on external websites. There is no financial data or detailed report content, only meeting decisions and procedural information. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short and it is not a full report or financial statement, so it is not an Annual Report or Interim Report. It is not a Regulatory Filing or Report Publication Announcement because it contains substantive board meeting resolutions rather than just a notice or certification.
2019-01-22 Chinese
关于大股东误操作造成短线交易的公告
Regulatory Filings Classification · 100% confidence The document is an announcement regarding a short-swing trading incident caused by a major shareholder's operational error. It details the shareholder's stock reduction plan, the erroneous buy order, the legal implications under securities law, and the company's response and measures taken. There are no financial statements, earnings data, or report attachments. The document is a regulatory announcement about insider trading compliance and shareholder conduct, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and focused on compliance and disclosure of a specific event, confirming it is not a full report or presentation.
2019-01-21 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.